Jim Cramer - Mad MoneyProgynyPRGNYBUYApr 05, 2024

A fertility benefits management company for employees. Rapid growth is not reflected in the stock. Been sideways since 2022, and delivered mixed numbers in February while the forecast was confusing though revenue and earnings projections were up.

Jim Cramer - Mad Money

Unknown

Unlock Rating

N/A

Stock price when the opinion was issued

Healthcare

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

Most Recent Experts

Jim Lebenthal

Cerity Partners

Joe Terranova

Virtus Investment Partners

Rob Sechan, Managing Partner, New Edge Capital

New Edge Capital

Stephanie Link, Chief investment strategist, Hightower

Hightower

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Jim Cramer - Mad MoneyProgynyPRGNYBUYApr 05, 2024

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals